Drugs / [F18]-FDDNP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02214862 | Mar 2013 → Dec 2015 | multiple system atrophy, parkinsonian disorder, progressive supranuclear palsy | Fundacion Clinic per a la Recerca Biomédica | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [F18]-FDDNP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02214862 ↗ |
| Modality | Diagnostic / imaging agent | “radiopharmaceutical tracer” NCT02214862 ↗ |
| Route | Intravenous | “intravenous” NCT02214862 ↗ |